From Operator to Owner: KIMS Picks Up 6% of Sangli's Ushahkal Abhinav Hospital for ₹15 Crore
The Hyderabad-headquartered hospital group, which already runs the 316-bed Sangli facility, will now also hold equity in it as it deepens its footprint in western India.
Krishna Institute of Medical Sciences (KIMS) is taking a direct ownership stake in a hospital it has been running for more than a year. The Hyderabad-headquartered group has agreed to invest ₹15 crore for a 6% share in Ushahkal Abhinav Speciality Hospital LLP in Sangli, Maharashtra. The deal is expected to close by 31 October 2026.
Where the relationship began
KIMS first came to Sangli as an operator, not an owner. Under an operations and management (O&M) contract signed on 17 February 2025, it took exclusive charge of running the 316-bed hospital for an initial seven years, earning 9% of the hospital's net revenue in return.
The new agreement adds a second layer to that arrangement. Alongside its management fee, KIMS will now share directly in the hospital's value and future performance.
About the hospital
Ushahkal Abhinav is a quaternary-care hospital — the most advanced level of specialist care — built on a four-acre campus in Sangli. It currently has 316 beds and room to grow to around 500.
KIMS has described the investment as a way to align operational efficiencies and play a bigger part in the hospital's growth.
Part of a wider expansion
The Sangli deal is one of several moves KIMS has made in quick succession, mixing management contracts, partnerships and selective equity bets:
- Guntur, Andhra Pradesh: on 6 October 2026, the board approved buying up to 51% of Insignia Healthcare, which runs the 150-bed KIMS-SIKHARA hospital.
- Kakinada, Andhra Pradesh: on 10 September 2026, KIMS signed a five-year O&M agreement with Sarvottam Health Care to operate a hospital in the city.
- Sangli, Maharashtra: the latest step, moving from a fee-only role to part-ownership.
The HealthBuzz take
Running a hospital first and buying into it later lets an operator see the books, the patient flow and the medical team before putting capital at risk. For KIMS, a modest 6% stake keeps the outlay small while giving it a foothold in a facility it already knows well, and a stronger base for growth in Maharashtra and the rest of western India.
Source: Company announcement
Comments (0)